Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBIT Margin (2020 - 2025)

Bio Essence has reported EBIT Margin over the past 6 years, most recently at 69.6% for Q4 2025.

  • Quarterly results put EBIT Margin at 69.6% for Q4 2025, up 6698.0% from a year ago — trailing twelve months through Dec 2025 was 47.43% (up 14359.0% YoY), and the annual figure for FY2025 was 47.43%, up 18926.0%.
  • EBIT Margin for Q4 2025 was 69.6% at Bio Essence, up from 10.42% in the prior quarter.
  • Over the last five years, EBIT Margin for BIOE hit a ceiling of 95.31% in Q4 2023 and a floor of 924.3% in Q1 2025.
  • Median EBIT Margin over the past 5 years was 64.0% (2022), compared with a mean of 102.76%.
  • Peak annual rise in EBIT Margin hit 41939bps in 2025, while the deepest fall reached -82562bps in 2025.
  • Bio Essence's EBIT Margin stood at 93.3% in 2021, then surged by 59bps to 38.64% in 2022, then skyrocketed by 347bps to 95.31% in 2023, then crashed by -97bps to 2.61% in 2024, then surged by 2566bps to 69.6% in 2025.
  • The last three reported values for EBIT Margin were 69.6% (Q4 2025), 10.42% (Q3 2025), and 23.63% (Q2 2025) per Business Quant data.